Russell D. Klein

1.3k total citations
24 papers, 1.1k citations indexed

About

Russell D. Klein is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Russell D. Klein has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Genetics. Recurrent topics in Russell D. Klein's work include Inflammatory mediators and NSAID effects (10 papers), Estrogen and related hormone effects (6 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Russell D. Klein is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Estrogen and related hormone effects (6 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Russell D. Klein collaborates with scholars based in United States and Germany. Russell D. Klein's co-authors include Susan M. Fischer, Xingya Wang, Peiying Yang, Robert A. Newman, Raymond B. Nagle, Diana Chan, Edward Felix, Timothy Madden, Kaoru Kiguchi and Steven K. Clinton and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Journal of Lipid Research.

In The Last Decade

Russell D. Klein

24 papers receiving 1.1k citations

Peers

Russell D. Klein
Gillian Hawcroft United Kingdom
Weigang Tong United States
Jason R. Mann United States
Keqin Tang United States
Xianzhong Ding United States
Phyllis H. Luckert United States
Sharada Katkuri United States
Gillian Hawcroft United Kingdom
Russell D. Klein
Citations per year, relative to Russell D. Klein Russell D. Klein (= 1×) peers Gillian Hawcroft

Countries citing papers authored by Russell D. Klein

Since Specialization
Citations

This map shows the geographic impact of Russell D. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell D. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell D. Klein more than expected).

Fields of papers citing papers by Russell D. Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell D. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell D. Klein. The network helps show where Russell D. Klein may publish in the future.

Co-authorship network of co-authors of Russell D. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Russell D. Klein. A scholar is included among the top collaborators of Russell D. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell D. Klein. Russell D. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sargeant, Aaron M., Samuel K. Kulp, Russell D. Klein, et al.. (2008). OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model. Cancer Research. 68(10). 3999–4009. 51 indexed citations
3.
Colby, Jennifer K., Russell D. Klein, Mark J. McArthur, et al.. (2008). Progressive Metaplastic and Dysplastic Changes in Mouse Pancreas Induced by Cyclooxygenase-2 Overexpression. Neoplasia. 10(8). 782–796. 71 indexed citations
4.
Sargeant, Aaron M., Russell D. Klein, Steven K. Clinton, et al.. (2007). Chemopreventive and Bioenergetic Signaling Effects of PDK1/Akt Pathway Inhibition in a Transgenic Mouse Model of Prostate Cancer. Toxicologic Pathology. 35(4). 549–561. 33 indexed citations
5.
Qin, Haiyan, Dimitrios Iliopoulos, Shuho Semba, et al.. (2006). A Role for the WWOX Gene in Prostate Cancer. Cancer Research. 66(13). 6477–6481. 90 indexed citations
6.
Yang, Peiying, Diana Chan, Edward Felix, et al.. (2006). Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids. Prostaglandins Leukotrienes and Essential Fatty Acids. 75(6). 385–395. 71 indexed citations
7.
Wang, Xingya & Russell D. Klein. (2005). Characterization of prostaglandin E2 receptors and their role in PGE2-induced VEGF expression in prostate cancer cells. Cancer Research. 65. 178–178. 1 indexed citations
8.
Klein, Russell D.. (2005). The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 576(1-2). 111–119. 21 indexed citations
9.
Whitman, Stephanie, et al.. (2005). Evidence for downregulation of calcium signaling proteins in advanced mouse adenocarcinoma. The Prostate. 64(2). 128–138. 8 indexed citations
10.
Yang, Peiying, Russell D. Klein, Edward Felix, et al.. (2004). An LC/MS/MS based method to analyze tissue eicosanoids: Application to EPA-mediated alteration of prostaglandin metabolism. Cancer Research. 64. 902–902. 1 indexed citations
11.
Yang, Peiying, Diana Chan, Edward Felix, et al.. (2004). Formation and antiproliferative effect of prostaglandin E3 from eicosapentaenoic acid in human lung cancer cells. Journal of Lipid Research. 45(6). 1030–1039. 93 indexed citations
12.
Rundhaug, Joyce E., Kathleen A. Hawkins, Amy Pavone, et al.. (2004). SAGE profiling of UV‐induced mouse skin squamous cell carcinomas, comparison with acute UV irradiation effects. Molecular Carcinogenesis. 42(1). 40–52. 38 indexed citations
13.
Bhatia, Bobby, Carlos J Maldonado, Shaohua Tang, et al.. (2003). Subcellular Localization and Tumor-suppressive Functions of 15-Lipoxygenase 2 (15-LOX2) and Its Splice Variants. Journal of Biological Chemistry. 278(27). 25091–25100. 60 indexed citations
14.
Tang, Shaohua, Bobby Bhatia, Carlos J Maldonado, et al.. (2002). Evidence That Arachidonate 15-Lipoxygenase 2 Is a Negative Cell Cycle Regulator in Normal Prostate Epithelial Cells. Journal of Biological Chemistry. 277(18). 16189–16201. 105 indexed citations
16.
Klein, Russell D., et al.. (2001). Aberrant expression of fibroblast growth factor receptor‐1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors. International Journal of Cancer. 91(2). 187–192. 23 indexed citations
17.
Klein, Russell D., Qingyi Wei, Yongli Guan, et al.. (2000). Low-dose genistein induces cyclin-dependent kinase inhibitors and G1 cell-cycle arrest in human prostate cancer cells. Molecular Carcinogenesis. 29(2). 92–102. 97 indexed citations
19.
Klein, Russell D., et al.. (1997). Interleukin-1β Secreted from Monocytic Cells Induces the Expression of Matrilysin in the Prostatic Cell Line LNCaP. Journal of Biological Chemistry. 272(22). 14188–14192. 33 indexed citations
20.
Zhao, Lue Ping, Lawrence H. Kushi, Russell D. Klein, & R. L. Prentice. (1991). Quantitative review of studies of dietary fat and rat colon carcinoma. Nutrition and Cancer. 15(3-4). 169–177. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026